<DOC>
	<DOCNO>NCT02629692</DOCNO>
	<brief_summary>Phase 1/2 study determine safety , tolerability , pharmacokinetics activity K0706</brief_summary>
	<brief_title>Safety , Tolerability Pharmacokinetic Study K0706</brief_title>
	<detailed_description />
	<criteria>Willing able give write , date , informed consent Male female age â‰¥ 18 year Willing able comply schedule visit Eastern Cooperative Oncology Group ( ECOG ) performance status 0 , 1 , 2 Any major surgery , determine Investigator , within 4 week IMP administration Inability undergo venipuncture and/or tolerate venous access Positive exclusion test : urine pregnancy test ( applicable ) , HIV , hepatitis B surface antigen , hepatitis C virus Known suspect history significant drug abuse judge Investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>